Webinar

Quality, Speed, Flexibility and Customer Focus in API Manufacturing: An Introduction to Cambrex

16th October 2014

Globally, Cambrex offers a variety of technology-driven products and services that accelerate the development of small molecule therapeutics from custom development to commercial manufacturing, including advanced chemical synthesis, enzymatic biotransformations, high potency APIs, high energy chemistry, controlled substances and formulation of finished dosage form products.

In this webinar, we examine how Cambrex works with large, mid-size, emerging and niche pharmaceutical companies to meet their changing small molecule needs and bring their products to market quickly.

Speakers

Dr. Matthew Moorcroft, VP of Global Marketing, Cambrex

Dr. Matthew Moorcroft, VP of Global Marketing, Cambrex

Bjarne Sandberg, Managing Director, Cambrex Karlskoga

Bjarne Sandberg, Managing Director, Cambrex Karlskoga

Joe Nettleton VP, Operations and Site Director, Cambrex Charles City

Joe Nettleton VP, Operations and Site Director, Cambrex Charles City

Tags About Cambrex Facilities Webinar